Lipella Pharmaceuticals Inc.(LIPO)

$0.13—

Chart

Lipella Pharmaceuticals Inc.(LIPO)

NASDAQ

$0.13—

Chart Studio

LIPO(LIPO)

LIPO

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-1.28

Sep 2, 2026

Revenue Estimate

$146,000

FY2028E EPS$0.40

FY2029E EPS$2.53

No analyst ratings available

Price Target Expectations

Bear

$2.00

+1438.5%

Consensus

$2.00

+1438.5%

Bull

$2.00

+1438.5%

12-Month Target Range0 analysts

$2.00$2.00$2.00

Current $0.13Consensus

Current Price

$0.13

Upside to Consensus

$1.87

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+4.32%

EPS—

FY2028

Rev+4231.04%

EPS—

FY2029

Rev+77.63%

EPS+532.50%

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E
Revenue Avg	$583,664	$608,860	$26M	$47M
Low	$583,664	$608,860	$26M	$47M
High	$583,664	$608,860	$26M	$47M
EBITDA Avg	$-473,448	$-493,886	$-21M	$-38M
Low	$-473,448	$-493,886	$-21M	$-38M
High	$-473,448	$-493,886	$-21M	$-38M
EBIT Avg	$-473,448	$-493,886	$-21M	$-38M
Low	$-473,448	$-493,886	$-21M	$-38M
High	$-473,448	$-493,886	$-21M	$-38M
Net Income Avg	$-18M	$-2M	$419,274	$3M
Low	$-18M	$-2M	$419,274	$3M
High	$-18M	$-2M	$419,274	$3M
EPS Avg	$-17.42	$-2.18	$0.40	$2.53
Low	$-17.42	$-2.18	$0.40	$2.53
High	$-17.42	$-2.18	$0.40	$2.53
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027
Revenue Avg	$146,000	$136,000	$80,000	—
Low	$146,000	$136,000	$80,000	—
High	$146,000	$136,000	$80,000	—
EBITDA Avg	$-118,430	$-110,318	$-64,893	—
Low	$-118,430	$-110,318	$-64,893	—
High	$-118,430	$-110,318	$-64,893	—
EBIT Avg	$-118,430	$-110,318	$-64,893	—
Low	$-118,430	$-110,318	$-64,893	—
High	$-118,430	$-110,318	$-64,893	—
Net Income Avg	$-6M	$-4M	$-47M	$-11M
Low	$-6M	$-4M	$-47M	$-11M
High	$-6M	$-4M	$-47M	$-11M
EPS Avg	$-1.28	$-0.96	$-10.33	$-2.43
Low	$-1.28	$-0.96	$-10.33	$-2.43
High	$-1.28	$-0.96	$-10.33	$-2.43
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	— / 1

Earnings Surprises

Recent Analyst Actions

Apr 9, 2024Maxim Group

Lipella Pharmaceuticals initiated with a Buy at Maxim

Target:$2.00

+183.9%from $0.70

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance